Galenica Aktie 36067446 / CH0360674466
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
10.09.2025 06:45:03
|
Launch of Galenica Diagnostics: Acquisition of Labor Team completed
|
Galenica AG
/ Key word(s): Takeover
Press release
Galenica has successfully completed the acquisition of Diagnostics Group GmbH (Labor Team Group including labor team w ag), one of Switzerland’s leading diagnostic service providers. The transaction was completed on 9 September 2025 with the approval of the Federal Competition Commission (COMCO) around two months after the acquisition was announced. By purchasing Labor Team, Galenica is entering the diagnostics business. Management and laboratory expertise on the Board of DirectorsIn future, Labor Team will be managed as an independent “Galenica Diagnostics” business unit in the Products & Care segment. The company will continue to operate on the market as a legally independent entity and brand. The new Board of Directors of labor team w ag brings together the management experience of the Galenica Group and specialist laboratory expertise. The current chairman of the board of directors, Ole Wiesinger, will continue to ensure stability in this role. Thomas Szuran, Chief Products & Home Care at Galenica, Julian Fiessinger, CFO of Galenica as well as Christian Rebhan, CEO Tentamus Group, and Ralph Panoff (current) are valuable additions to the board. Rahel Kubik, who has been a member of the Board of Directors to date, will be stepping down from the Board. Labor Team and Galenica would like to thank her for her dedication over the past years. The current management team of Labor Team headed by CEO Alain M. Cahen will maintain operational responsibility. Expanding the healthcare networkIn acquiring Labor Team, Galenica is adding a leading diagnostic service provider with a strong market position to its healthcare network. In addition to the existing offerings in the area of drugs and products for the physician market, it will also be possible to offer innovative laboratory services as a single provider. In the long term, Galenica is planning to develop an innovative range of selected diagnostic laboratory services within the scope of the regulatory possibilities in pharmacies. This will further strengthen healthcare provision in Switzerland. Further details: Press release dated 02 July 2025 Dates for the diary
For further information, please contact
Welcome to the Galenica network! Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Additional information about Galenica can be found at www.galenica.com.
End of Media Release |
| Language: | English |
| Company: | Galenica AG |
| Untermattweg 8 | |
| 3027 Bern | |
| Switzerland | |
| Phone: | +41 058 852 81 11 |
| E-mail: | info@galenica.com |
| Internet: | https://www.galenica.com |
| ISIN: | CH0360674466 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 2194402 |
| End of News | EQS News Service |
|
|
2194402 10.09.2025 CET/CEST
Nachrichten zu Galenica AG
|
22.10.25 |
Galenica Aktie News: Galenica zeigt sich am Mittwochnachmittag fester (finanzen.ch) | |
|
22.10.25 |
Galenica Aktie News: Galenica schiebt sich am Mittag vor (finanzen.ch) | |
|
22.10.25 |
SPI-Titel Galenica-Aktie: So viel hätten Anleger an einem Galenica-Investment von vor einem Jahr verdient (finanzen.ch) | |
|
22.10.25 |
Galenica Aktie News: Galenica am Mittwochvormittag mit positiven Vorzeichen (finanzen.ch) | |
|
21.10.25 |
Galenica strengthens basic care with new pharmacy concept (EQS Group) | |
|
21.10.25 |
Galenica stärkt Grundversorgung mit neuem Apothekenkonzept (EQS Group) | |
|
08.10.25 |
SPI-Wert Galenica-Aktie: So viel hätten Anleger an einem Galenica-Investment von vor 5 Jahren verdient (finanzen.ch) | |
|
01.10.25 |
SPI-Titel Galenica-Aktie: So viel Gewinn hätte eine Investition in Galenica von vor 3 Jahren abgeworfen (finanzen.ch) |
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Iberdrola
✅ Interactive Brokers
✅ Swiss Life Holding
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Galenica AG | 89.80 | 0.45% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI schliesslich kaum verändert -- DAX beendet Handel im Minus -- Wall Street fällt bis Handelsende -- Asien Börsen letztlich in RotDer heimische Aktienmarkt bewegte sich zur Wochenmitte seitwärts, während das deutsche Börsenbarometer Verluste einsteckte. Auch die Wall Street zeigte sich mit Abgaben. Die Börsen in Fernost notierten am Mittwoch im Minus.